Compare Medtronic PLC (MDT) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Southern Copper Corp — how do they compare? Medtronic PLC trades at $82.52 (market cap $106.61B), while Southern Copper Corp trades at $185.85 (market cap $146.07B). The key difference: Southern Copper Corp is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.46%). Which is the better fit depends on your goals.
| MDT | SCCO | |
|---|---|---|
Market Cap | $106.61B | $146.07B |
Sector | Health | Basic Materials |
52-Week High | $105.35 | $218.85 |
52-Week Low | $73.75 | $90.54 |
Enterprise Value | $125.36B | $148.12B |
Dividend Yield | 3.46% | 2.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Southern Copper (SCCO) trades at $175.27, up 1.62% on the day, with a bearish technical signal despite recent earnings beats. The company shows strong fundamentals with revenue growth from $11.4B in 2024 to $13.4B in 2025 and net income rising to $4.3B. Valuation ratios are elevated with a P/E of 29.2 and P/B of 12.2. A recent dividend of $1.00 was declared, payable May 29, 2026, alongside a minor stock split.
Outlook is mixed: robust profitability and copper demand from AI infrastructure support growth, but high valuation and bearish analyst consensus pose risks. The consensus price target is $152.79, below the current price, indicating potential downside. Key risks include commodity price volatility and debt levels, though operational cash flow remains strong at $4.75B in 2025.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
